U.S. Temperature Modulation Devices Market Size, Share & Trends Analysis Report by Product (Portable Blood/IV Warming Devices, Convective Patient Warming Systems, Conductive Patient Cooling Systems), and Segment Forecasts, 2024-2030

The U.S. temperature modulation devices market size is anticipated to reach USD 1.60 billion by 2030, growing at a CAGR of 6.4% from 2024 to 2030. The increasing number of surgical procedures and the growing popularity of ambulatory surgeries in the U.S. drive the temperature modulation devices market. These devices are utilized during and after surgery to regulate a patient's body temperature, prevent hypothermia or hyperthermia, and promote optimal surgical outcomes.

Furthermore, the increasing prevalence of chronic diseases such as cardiovascular disorders and neurological conditions is a significant factor contributing to the market growth. The growing prevalence of chronic diseases necessitates developing and adopting innovative medical devices, such as temperature modulators, for improved patient care and outcomes.

Continuous technological advancements is a key demand driver for temperature modulation devices in the U.S. Innovations such as advanced cooling systems, precise temperature monitoring capabilities, and improved safety features have enhanced the effectiveness and efficiency of these devices. Healthcare providers are increasingly adopting these advanced technologies to improve patient outcomes and enhance the quality of care. For instance, in July 2023, ZOLL Medical Corporation announced the signing of an exclusive agreement with BrainCool AB to distribute BrainCool System/IQool System and the IQool System Pads in the U.S. The agreement expands Zoll's temperature management solutions to include surface and intravascular technology options.

U.S. Temperature Modulation Devices Market Report Highlights

• Based on product, the convective patient warming systems sector dominated the market with more than 27.9% revenue share in 2023 and is expected to grow at the fastest CAGR from 2024 to 2030
• This growth of the convective patient warming systems segment can be attributed to advancements in technologies, increasing prevalence of hypothermia, rising number of surgical procedures, and growing focus on patient improvement
• January 2024, The Surgical Company launched TSC Life, a global medical technology company focused on ICU, OR, and urology. TSC Life results from merging The Surgical Company's business units, focusing on single-use endoscopy and patient temperature management (PTM).

Why should you buy this report?

• Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
• Competitive Landscape: Explore the market presence of key players worldwide.
• Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
• Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

• Market intelligence to enable effective decision-making
• Market estimates and forecasts from 2018 to 2030
• Growth opportunities and trend analyses
• Segment and regional revenue forecasts for market assessment
• Competition strategy and market share analysis
• Product innovation listing for you to stay ahead of the curve
• COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.